Extracorporeal CO2 Removal Devices Size, Share, & Strategies|2030
市场洞察和分析师观点：
慢性阻塞性肺疾病 (COPD) 病例增加和老年人口增加等因素推动了体外二氧化碳的增长去除设备市场的增长。然而，与体外二氧化碳去除装置相关的严格要求阻碍了市场的增长。
体外二氧化碳去除装置安全、有效且可行。建议在临床情况下使用体外二氧化碳清除装置进行通气支持，这些装置可能有助于解决慢性阻塞性肺病和急性呼吸窘迫综合征的恶化问题。一些制造商专注于开发技术先进和创新的体外二氧化碳去除设备并巩固其市场地位。此外，越来越多易患慢性阻塞性肺病的老年人正在接受体外二氧化碳清除装置插管，以提高他们的生存率。因此，肺阻塞性疾病发病率的增加是导致体外二氧化碳清除装置市场规模不断扩大的因素之一。相反，使用体外CO2去除装置存在感染、低氧血症或循环系统血流受限而形成血栓的风险，会导致严重的健康问题，并对市场扩张构成长期挑战。
增长动力：
慢性阻塞性肺疾病病例的增加推动了体外二氧化碳清除设备市场
根据 2019 年疾病负担研究，全球记录了 2.123 亿慢性阻塞性肺病病例和 330 万慢性阻塞性肺病相关死亡病例。慢性阻塞性肺病等呼吸道疾病的主要原因之一是日益严重的空气污染。此外，经济合作与发展组织 (OECD) 表示，由于二氧化碳排放量增加至 70%，预计到 2050 年全球温室气体排放量将激增约 50%。此外，据估计，到 2050 年，大气中温室气体浓度可能达到百万分之 685 (ppm) 二氧化碳当量，这将导致平均气温比工业化前水平上升 3–6°C。
2021 年 1 月根据发表在 PLoS ONE 杂志上的研究，法国约有 260 万人患有慢性阻塞性肺病 (COPD)。到 2025 年，这一数字预计将增至 280 万。根据英国国家健康科学发布的 2022 年统计数据，2020-21 年英国约有 117 万人被诊断为慢性阻塞性肺病，占总人口的 1.9%。据世界卫生组织称，慢性阻塞性肺病被认为是全球第三大死因，到 2022 年将导致约 320 万人死亡。此外，根据美国肺脏协会的数据，美国每年有超过 1100 万人被诊断患有慢性阻塞性肺病。因此，人口中慢性阻塞性肺病的高负担增加了对体外二氧化碳去除装置的需求，以促进血流和有效的气体交换，从而推动体外二氧化碳去除装置市场的增长。
报告细分和范围：
“体外 CO2 去除装置市场分析”是通过考虑以下细分市场进行的：产品、应用和最终用户。
细分分析：
按应用划分，体外 CO2 去除装置市场是分为急性呼吸窘迫综合征、慢性阻塞性肺病等。慢性阻塞性肺疾病细分市场在 2022 年占据最大的市场份额。预计急性呼吸窘迫综合征细分市场在预测期内复合年增长率最高，为 7.7%。人们对 ARDS 及其早期检测的认识不断提高，导致更多患者得到诊断和治疗，从而导致对针对 ARDS 管理量身定制的体外 CO2 去除设备的需求更大。因此，医疗保健提供者对将体外 CO2 去除装置纳入其 ARDS 治疗方案变得更有信心。
体外 CO2 去除装置可以降低呼吸频率和潮气量，从而延长呼气时间，从而更好地适应呼吸系统的高呼气时间常数。据英国肺脏协会称，英国约有 120 万人患有慢性阻塞性肺病 (COPD)。因此，慢性阻塞性肺病（COPD）患病率的不断上升预计将加速全球体外二氧化碳去除设备市场的发展。
体外二氧化碳去除设备市场，按应用划分 - 2022 年和 2030 年
体外二氧化碳去除设备市场，按产品划分进入体外二氧化碳设备和消耗品。到 2022 年，体外 CO2 设备领域将占据更大的市场份额。预计消耗品领域在预测期内的复合年增长率将达到 7.6%。由于技术简化，体外二氧化碳去除装置需要少量人员和后勤，从而增加了患者的偏好。这使得体外 CO2 去除设备领域巩固了其市场地位。
体外 CO2 去除过程需要为每位患者提供一套新的耗材，因此各种 COPD 和 ARDS 相关耗材的需求很高程序。因此，消耗品领域的体外二氧化碳去除装置市场预计将在预测期内继续增长。
按最终用户划分，市场分为医院和诊所、门诊手术中心等。到 2022 年，医院和诊所领域将占据最大的体外二氧化碳去除设备市场份额，预计在预测期内复合年增长率最高，为 7.4%。医院，特别是那些拥有专门重症监护病房（ICU）和呼吸设施的医院，有能力照顾病情最严重的患者。此外，医院通常拥有由医疗保健专业人员组成的多学科团队，包括肺科医生、重症监护医生、呼吸治疗师和灌注师，他们共同努力治疗有复杂呼吸需求的患者。这种专业知识对于安全有效地使用 ECCO2R 设备至关重要。
不断发展的技术进步可加速体外 CO2 去除设备市场
较小的体外 CO2 去除设备侵入性更小，对患者来说更舒适。它们通常需要较小的血管通路，从而降低并发症的风险。由于患者不再受大型固定设备的束缚，因此他们可以体验到更大的活动性和舒适度，从而提高整体治疗质量。膜技术的进步显着提高了体外二氧化碳去除装置的有效性和功效。它们选择性地允许二氧化碳扩散，同时保留重要的血液成分，例如红细胞和蛋白质。这种选择性最大限度地降低了溶血和其他血液相关并发症的风险。
由于健康状况恶化，老年人群更需要维持生活质量，体外二氧化碳去除装置在提供更少的血液方面发挥着重要作用。有创且更温和的呼吸支持。体外二氧化碳去除 (ECCO2R) 技术的进步促进了更多用户友好型便携式设备的开发。随着 ECCO2R 的益处日益得到认可，它越来越多地被纳入老年人的治疗计划中。因此，不断增长的技术进步可能会在未来几年带来新的体外二氧化碳去除装置市场趋势。
区域分析：
体外二氧化碳去除装置市场报告的范围涉及北美、欧洲、亚太地区、南美和南太平洋地区。中美洲、中东和非洲。
2022 年，北美拥有最大的体外 CO2 去除装置市场份额。该地区的市场增长得益于医疗基础设施的改善和体外二氧化碳去除设备的广泛采用，特别是在美国和加拿大的 COVID-19 大流行期间。新技术的早期采用以及 ARDS 和 COPD 的庞大患者库预计将加速该地区市场的增长。慢性呼吸系统疾病发病率的增加以及对安全快速微创呼吸机的偏好预计将进一步加速预测期内体外二氧化碳去除设备市场的增长。
欧洲体外二氧化碳去除设备市场预计将占据全球市场第二大份额。这是由于该地区对医疗设备的需求不断增加，加上呼吸衰竭等慢性病的患病率不断增加。此外，有利的报销政策、政府对长期医疗保健投资的增加以及不断发展的医疗保健研究基础设施正在提高体外二氧化碳去除设备的利用率。
亚太地区的体外二氧化碳去除设备市场预计将见证最快的增长预测期内增长率为 7.3%。这一增长是由于印度和日本等发展中国家的患者群体庞大、人们对急性呼吸衰竭的认识不断提高以及政府医疗支出的增加。此外，跨国公司期待在中国等发展中国家进行投资，从而促进该地区的市场增长。
行业发展和未来机遇：
体外二氧化碳去除装置市场预测可以帮助该市场的利益相关者规划他们的增长战略。下面列出了市场领先企业的一些战略发展：
2022 年 10 月，ALung Technologies 评估了使用 hemolung 呼吸辅助系统 (RAS) 进行低流量体外 CO2 去除 (ECCO2R) 的安全性和有效性：对于因慢性阻塞性肺疾病 (COPD) 急性加重而需要呼吸支持的患者来说，有创机械通气的替代方案或辅助疗法。 2022 年 3 月，美国呼吸健康技术公司 Respira Labs 推出了 Sylvee。这款人工智能驱动的可穿戴肺监测仪利用声共振来评估肺功能并识别肺容量波动。它可以帮助检测和治疗慢性阻塞性肺病、哮喘和 COVID-19。 2021 年 5 月，ALung Technologies, Inc. 的下一代 Hemolung RAS 体外二氧化碳清除系统获得 FDA 批准，该系统旨在为患有慢性阻塞性肺病的患者提供呼吸支持2020 年 5 月，ALung Technologies, Inc. 宣布商业开发名为 hemolung RAS 的下一代人工肺。竞争格局和主要公司：
Getinge、ALung Technologies, Inc.； Estor、NovaLung GmbH、Hemodec、Baxter Healthcare、Eurosets、LivaNova、Medtronic 和 Xenios AG 都是体外二氧化碳清除设备市场报告中介绍的知名公司。这些公司专注于开发新技术、升级现有产品并扩大其地域分布，以满足全球不断增长的消费者需求。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors driving the growth of the extracorporeal CO2 removal devices market include the increasing cases of chronic obstructive pulmonary diseases (COPD) and growing geriatric population.
The extracorporeal CO2 removal devices market majorly consists of the players such as Getinge, ALung Technologies, Inc.; Estor, NovaLung GmbH, Hemodec, Baxter Healthcare, Eurosets, LivaNova, Medtronic, and Xenios AG.
Extracorporeal CO2 removal devices are an efficient therapy for patients with hypercapnic respiratory failure. They can enable doctors and healthcare professionals to improve lung protective ventilation. Extracorporeal CO2 removal devices can remove enough CO2 to reduce alveolar minute ventilation by 50%, significantly reducing the partial pressure of carbon dioxide (PaCO2). Therefore, various advantages of extracorporeal CO2 removal devices are expected to increase the overall market development.
The global extracorporeal CO2 removal devices market, based on product is bifurcated into extracorporeal CO2 devices and consumables. The extracorporeal CO2 devices segment held a larger market share in 2022. The consumables segment is anticipated to register a higher CAGR of 7.6% during the forecast period. Based on application, the market is segmented into acute respiratory distress syndrome, chronic obstructive pulmonary disease, and others. The chronic obstructive pulmonary disease segment held the largest market share in 2022. The acute respiratory distress syndrome segment is anticipated to register the highest CAGR of 7.7% during 2022–2030. In terms of end user, the extracorporeal CO2 removal devices market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest extracorporeal CO2 removal devices market share in 2022 and is anticipated to register the highest CAGR of 7.4% during 2022–2030.
The hyperbaric oxygen therapy market was valued at US$ 99.93 million in 2022.
The hyperbaric oxygen therapy market is expected to be valued at US$ 170.54 million in 2030.
The List of Companies - Extracorporeal CO2 Removal Devices Market
- Getinge
- ALung Technologies, Inc.
- Estor
- NovaLung GmbH
- Hemodec
- Baxter Healthcare
- Eurosets
- LivaNova
- Medtronic
- Xenios AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For